CIRM is governed by 35 dedicated Californians representing patients, researchers and the biotechnology industry whose knowledge, passion and commitment to CIRM’s mission has guided the organization ...
1) Successfully developed ART352-L, a liposomal formulation of recombinant human WNT3A protein, that is applied ex vivo, to harvested autologous bone graft (autograft) to enhance the osteogenic ...
Las reuniones de la CFAOC están organizadas por la Oficina del Contralor del Estado. A continuación, se incluye una copia de la agenda publicada en https://www.sco ...
have the ability to divide and create an identical copy of themselves, a process called self-renewal; and can also divide to form cells that mature into cells that make up every type of tissue and ...
Therapeutic Translational Research Projects University of California, Los Angeles COVID-19 Antiviral Therapy to Block Direct Cell Injury and Associated Tissue Damage $349,999 Quest – Discovery Stage ...
There is no shortage of myths and misconceptions when it comes to stem cell research and regenerative medicine. Here we address the most common concerns. If you have more questions that aren’t ...
Retinal degeneration represents a group of blinding diseases that are increasingly impacting the health and well being of Californians. It is estimated that by 2020, over 450,000 Californians will ...
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and ...
About 6,000 people are diagnosed with ALS (also known as Lou Gehrig’s disease) each year in the U.S., and the average survival time is two to five years. The disease results when the cells in the ...
Deborah K. Armstrong Johns Hopkins University Ovarian, Breast Cancer and Gynecologic Cancer Clinical Trials; Genetics of Familial Breast and Ovarian Cancer ...
Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.
San Francisco, CA – California’s stem cell agency, the California Institute for Regenerative Medicine (CIRM) today approved $150 million in new funding to help move promising stem cell-based therapies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback